查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496688

连续肾臟替代疗法市场：按产品、方式、年龄层、适应症和最终用户 - 2024-2030 年全球预测

Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

持续性肾臟替代治疗市场规模预计2023年为142.8亿美元，2024年达到154.9亿美元，预计2030年将达到253.7亿美元，复合年增长率为8.55%。

连续性肾臟替代疗法（CRRT）是一种用于连续透析以维持溶质和液体稳态的专门治疗方法。 CRRT 透过模仿肾臟从血液中清除废物、多余液体和电解质的自然功能，同时保持最佳酸碱平衡，提供持续的肾臟支持。由于多种因素，CRRT 经历了显着增长，包括全球 AKI 盛行率的增加以及体外透析和碎石术的技术进步。此外，CRRT在间歇性血液净化方面的显着优势正在推动市场扩张。然而，对肾臟替代治疗的高成本和治疗期间潜在併发症的担忧阻碍了 CRRT 的发展。此外，持续的技术创新和研究工作正在为 CRRT 的未来做出贡献，包括开发具有改进的生物相容性的新型膜材料、先进的治疗方法以及扩大 CCRT 系统在儿科患者中的应用。

主要市场统计
基准年[2023] 142.8亿美元
预测年份 [2024] 154.9亿美元
预测年份 [2030] 253.7亿美元
复合年增长率（%） 8.55%

区域洞察

在美洲，美国和加拿大等国家占据了 CRRT 市场的很大份额，推动成长的主要因素是肾臟疾病盛行率的增加、技术进步和主要参与者的研发活动。此外，在欧洲，主要製造商的存在、对先进治疗的需求不断增加以及政府支持政策（例如肾臟治疗产品的欧洲 CE 标誌）都有助于 CRRT 市场的扩张。同时，在中东和非洲地区，由于人们对肾臟疾病的认识不断提高，以及采用临床研究支持的新治疗方法的医疗基础设施不断发展，对 CRRT 解决方案的需求不断增加。在亚太地区，中国、日本和印度是 CRRT 市场成长的主要贡献者。这是由于大量肾臟病患者、不断发展的医疗旅游业、不断扩大的医疗基础设施以及允许在该地区快速采用先进技术的研究等因素造成的，因为重点是倡议。因此，製造商透过调整监管合规措施并与政府和组织建立策略联盟来保持敏捷性，以在 CRRT 市场上留下印记。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在连续性肾臟替代治疗市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对连续性肾臟替代治疗市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在连续性肾臟替代治疗市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 急性肾损伤（AKI）和慢性肾臟病（CKD）的发生率上升
      • 为儿科和新生儿患者提供改良的 CCRT 系统
    • 抑制因素
      • 连续性肾臟替代治疗程序的高成本
    • 机会
      • 持续研发以提高 CRRT 的安全性和有效性
      • CRRT 设备和技术获得政府有利核准
    • 任务
      • 与连续性肾臟替代治疗相关的技术问题
  • 市场区隔分析
    • 产品：急性肾损伤 (AKI) 盛行率的不断上升增加了对 CRRT 设备进行无缝治疗程序的需求。
    • 方法：利用连续性静脉血液滤过透析进行肾臟治疗中的自由水管理
    • 年龄层：儿科族群 CRRT 要求的差异
    • 适应症：在体外肾臟治疗中越来越多地采用非肾臟适应症
    • 最终用户：增加医院中 CRRT 设备的使用以满足病患需求
  • 市场趋势分析
    • 北美现有公司的 CRRT 已获得政府的有利核准，并且还有扩展到南美市场的潜力。
    • 亚洲肾臟病患者数量的增加增加了持续肾臟替代治疗的需求
    • 支持性肾臟健康政策和现有供应商的财务承诺促进了 CRRT 在欧洲、中东和非洲地区的发展。
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章连续肾臟替代治疗市场：副产品

  • CRRT系统
  • 透析液和置换液
  • 一次性的

第七章连续肾臟替代治疗市场：按方式

  • 连续性静脉血液滤过透析
  • 连续性静脉血液透析机
  • 连续性静脉血液滤过
  • 低速连续超过滤

第八章连续肾臟替代治疗市场：依年龄组

  • 成人
  • 小儿科

第九章连续肾臟替代治疗市场（按适应症）

  • 非肾
  • 肾

第10章连续肾臟替代治疗市场：依最终用户分类

  • 透析诊所
  • 居家护理
  • 医院

第十一章美洲连续肾臟替代治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区持续肾臟替代治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲连续性肾臟替代治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • B. Braun 的 AQUAbase nX逆渗透系统获得 FDA 批准
    • Quanta 获得 FDA 510(k)核准，扩大连续性肾臟替代治疗的适应症
    • Rockwell Medical 宣布与 B. Brown Medical 建立为期三年的共同促销合作伙伴关係
    • Nuwellis 和 DaVita 合作开展超过滤治疗试验计画
    • Baxter 和 Miromatrix 合作研究肝功能衰竭
    • PBMC 为透析患者推出新的肾臟治疗方案
    • Sea Star Medical 与 Nuweris 合作治疗肾臟疾病
    • Spectral Medical 宣布与 Infomed 成立策略合资企业，以加速 DIMI 和 SAMI透析设备的商业化。
    • 百特宣布美国FDA核准用于治疗医院急性肾衰竭患者的 ST 装置

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-433AB1DC293A

[187 Pages Report] The Continuous Renal Replacement Therapy Market size was estimated at USD 14.28 billion in 2023 and expected to reach USD 15.49 billion in 2024, at a CAGR 8.55% to reach USD 25.37 billion by 2030.

Continuous renal replacement therapy (CRRT) is a specialized medical treatment utilized for continuous dialysis to allow solute and fluid homeostasis. CRRT provides continuous renal support by mimicking the natural function of the kidneys in removing waste products, excess fluids, and electrolytes from the blood while maintaining optimal acid-base balance. The CRRT is witnessing significant growth due to several factors, including the increasing prevalence of AKI incidences globally and rising technological advancements in extracorporeal dialysis and lithotripsy. In addition, significant advantages of CRRT in intermittent blood purification boost the market expansion. However, the high cost associated with the renal replacement procedure and concerns over potential complications during therapies subsequently hampers the growth of CRRT. Moreover, ongoing innovation and research activities, including developing novel membrane materials and advanced therapy options with improved biocompatibility and widening uses of CCRT systems for pediatric patients, contribute to the future CRRT.

KEY MARKET STATISTICS
Base Year [2023] USD 14.28 billion
Estimated Year [2024] USD 15.49 billion
Forecast Year [2030] USD 25.37 billion
CAGR (%) 8.55%

Regional Insights

In the Americas, countries such as the United States and Canada hold a significant share of the CRRT market, with the major factors driving the growth, including the increasing prevalence of renal diseases and technological advancements and research & development activities by major companies. Additionally, in Europe, the presence of leading manufacturers, increased need for advanced therapies, and supportive government policies, such as European CE marking for renal therapy products, contribute to the expansion of the CRRT market. On the other hand, the Middle East and Africa region has witnessed a growth in need for CRRT solutions due to rising awareness about renal diseases and continuously developing healthcare infrastructure adopting new treatment options supported by clinical studies. In Asia-Pacific, China, Japan, and India are major contributors to the CRRT market growth due to factors including a large patient pool with kidney disorders, a growing medical tourism industry, and expanding healthcare infrastructure, coupled with an increasing focus on research initiatives enabling rapid adoption of advanced technologies in this region. As a result, manufacturers remain agile by adapting regulatory compliance measures and participating in strategic collaborations with governments and entities to form footprints in the CRRT market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Continuous Renal Replacement Therapy Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
      • Availability of improved CCRT systems for pediatric and neonatal patients
    • Market Restraints
      • High cost of continuous renal replacement therapy procedure
    • Market Opportunities
      • Ongoing research and development for enhanced safety and efficacy of CRRT
      • Favorable government approvals for CRRT machines and techniques
    • Market Challenges
      • Technical complications associated with continuous renal replacement therapy
  • Market Segmentation Analysis
    • Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
    • Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
    • Age Group: Differing CRRT requirements among pediatric population
    • Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
    • End User: Increasing uses of CRRT devices in hospitals to cater a patients need
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Continuous Renal Replacement Therapy Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Continuous Renal Replacement Therapy Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System

B. Braun Medical Inc. has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AQUAbase nX Reverse Osmosis System. This innovative device offers dialysis patients access to high-quality water without the use of chemicals, boasting an impressive raw water conversion rate of up to 75%. [Published On: 2023-09-18]

Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies

Quanta Dialysis Technologies, a medical technology company, has announced that its Quanta Dialysis System has received FDA 510(k) approval for an expanded indication. This compact and user-friendly hemodialysis device now offers Continuous Renal Replacement Therapy (CRRT), including Continuous VenoVenous Hemodialysis (CVVHD) and Slow Continuous Ultrafiltration (SCUF). The Quanta Dialysis System stands out as the only dialysis device cleared by the FDA to provide Intermittent Hemodialysis (IHD), Sustained Low-Efficiency Dialysis (SLED), and Bagless CRRT. [Published On: 2023-08-03]

Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical

Rockwell Medical, Inc., a healthcare company, has entered into a 3-year co-promotion services agreement with B. Braun Medical Inc. As part of the agreement, B. Braun is planned to be compensated for any sales resulting from its promotional efforts. This strategic partnership allows Rockwell Medical to expand its customer base and generate new business leads, ultimately improving the lives of more hemodialysis patients. [Published On: 2023-06-29]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Continuous Renal Replacement Therapy Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment Co., Ltd., Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Biomedica Medizinprodukte GmbH, Braun & Co. Limited, CytoSorbents Corporation, DIAMED Medizintechnik GmbH, Fresenius Medical Care AG & Co. KGaA, Infomed SA, Joline GmbH & Co. KG, Medites Pharma spol. s.r.o, Medtronic PLC, Miromatrix Medical Inc., Nextkidney B.V., Nikkiso Co., Ltd., Ningbo Tianyi Medical Devices Co., Ltd., Nipro Corporation, Nuwellis, Inc., Quanta Dialysis Technologies Limited, SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, Sphingotec GmbH, SWS Hemodialysis Care Co. Ltd., Thermo Fisher Scientific Inc., and Toray Medical Co., Ltd. by Toray Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • CRRT Systems
    • Dialysates & Replacement Fluids
    • Disposables
      • Bodyline sets & tubes
      • Hemofilters
  • Modality
    • Continuous Venovenous Hemodiafiltration
    • Continuous Venovenous Hemodialysis
    • Continuous Venovenous Hemofiltration
    • Slow Continuous Ultrafiltration
  • Age Group
    • Adults
    • Pediatrics
  • Indication
    • Non-renal
    • Renal
  • End User
    • Dialysis Clinics
    • Homecare
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
      • 5.1.1.2. Availability of improved CCRT systems for pediatric and neonatal patients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of continuous renal replacement therapy procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
      • 5.1.3.2. Favorable government approvals for CRRT machines and techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications associated with continuous renal replacement therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
    • 5.2.2. Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
    • 5.2.3. Age Group: Differing CRRT requirements among pediatric population
    • 5.2.4. Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
    • 5.2.5. End User: Increasing uses of CRRT devices in hospitals to cater a patients need
  • 5.3. Market Trend Analysis
    • 5.3.1. Established companies in the North America receiving favorable government approvals for CRRT and their potential expansion in the South American market
    • 5.3.2. Growing number of renal patients in Asia leads to an increased need for continuous renal replacement therapies
    • 5.3.3. Supportive government policies and financial initiatives from established vendors for the kidney health contributed to CRRT advancement across EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Continuous Renal Replacement Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. CRRT Systems
  • 6.3. Dialysates & Replacement Fluids
  • 6.4. Disposables

7. Continuous Renal Replacement Therapy Market, by Modality

  • 7.1. Introduction
  • 7.2. Continuous Venovenous Hemodiafiltration
  • 7.3. Continuous Venovenous Hemodialysis
  • 7.4. Continuous Venovenous Hemofiltration
  • 7.5. Slow Continuous Ultrafiltration

8. Continuous Renal Replacement Therapy Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Pediatrics

9. Continuous Renal Replacement Therapy Market, by Indication

  • 9.1. Introduction
  • 9.2. Non-renal
  • 9.3. Renal

10. Continuous Renal Replacement Therapy Market, by End User

  • 10.1. Introduction
  • 10.2. Dialysis Clinics
  • 10.3. Homecare
  • 10.4. Hospitals

11. Americas Continuous Renal Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System
    • 14.3.2. Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies
    • 14.3.3. Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
    • 14.3.4. Nuwellis, DaVita partner on ultrafiltration therapy pilot program
    • 14.3.5. Baxter, Miromatrix Partner on Liver Failure Research
    • 14.3.6. PBMC Launches New Renal Therapy Option for Dialysis Patients
    • 14.3.7. SeaStar Medical, Nuwellis Partner on Kidney Injury Treatment
    • 14.3.8. Spectral Medical Announces Strategic Joint Venture with Infomed to Accelerate Commercialization of DIMI and SAMI Dialysis Devices.
    • 14.3.9. Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BODYLINE SETS & TUBES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)

TABLE 299